Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Sarabjit Chadha"'
Autor:
Heidi Albert, Sidharth Rupani, Enos Masini, Jeremiah Ogoro, Maureen Kamene, Donna Geocaniga-Gaviola, Eddie Sistoso, Celina Garfin, Sarabjit Chadha, Nishant Kumar, Kekeletso Kao, Zachary Katz
Publikováno v:
PLoS ONE, Vol 18, Iss 11 (2023)
Externí odkaz:
https://doaj.org/article/b35f29343a3b467ea06373c8802ad3a9
Autor:
Debashish Kundu, Nandini Sharma, Sarabjit Chadha, Samia Laokri, George Awungafac, Lai Jiang, Miqdad Asaria
Publikováno v:
Health Economics Review, Vol 8, Iss 1, Pp 1-12 (2018)
Abstract Introduction There are significant financial barriers to access treatment for multi drug resistant tuberculosis (MDR-TB) in India. To address these challenges, Chhattisgarh state in India has established a MDR-TB financial protection policy
Externí odkaz:
https://doaj.org/article/6a8c851ffd10410c87d4087c8e757127
Publikováno v:
Tobacco Induced Diseases, Vol 16, Iss 1 (2018)
Background In 2016, India estimated about 2.8 million tuberculosis (TB) cases (Global TB Report 2017) and about 267 million adults (>15years) in India using tobacco in any form (GATS 2017). Tobacco is one of the important drivers of TB epidemic. The
Externí odkaz:
https://doaj.org/article/b646b7dac1db4f5080faeb1a774ee850
Is Chemoprophylaxis for Child Contacts of Drug-Resistant TB Patients Beneficial? A Systematic Review
Autor:
C. Padmapriyadarsini, Mrinalini Das, Sharath Burugina Nagaraja, Mahalakshmi Rajendran, Richard Kirubakaran, Sarabjit Chadha, Prathap Tharyan
Publikováno v:
Tuberculosis Research and Treatment, Vol 2018 (2018)
Background. Preventive therapy for child contacts of multidrug-resistant tuberculosis (MDR-TB) patients is poorly studied, and no consensus about the role and the rationale of chemoprophylaxis has been reached. Objective. To conduct systematic review
Externí odkaz:
https://doaj.org/article/0442d75fb4f54a549fd9f97e78ccb089
Autor:
Mahasweta Satpati, Sharath Burugina Nagaraja, Hemant Deepak Shewade, Prabhakaran Ottapura Aslesh, Blesson Samuel, Ashwani Khanna, Sarabjit Chadha
Publikováno v:
Tuberculosis Research and Treatment, Vol 2017 (2017)
Objective. To identify the challenges encountered by private health care providers (PHCP) to notify tuberculosis cases through a programme developed web-based portal mechanism called “NIKSHAY.” Study Design. It is a descriptive qualitative study
Externí odkaz:
https://doaj.org/article/a2be33acb99f428284d1d270f408ce47
Autor:
Lord Wasim Reza, Srinath Satyanarayna, Donald A Enarson, Ajay M V Kumar, Karuna Sagili, Sujeet Kumar, Levi Anand Prabhakar, N M Devendrappa, Ashish Pandey, Nevin Wilson, Sarabjit Chadha, Badri Thapa, Kuldeep Singh Sachdeva, Mohan P Kohli
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e75566 (2013)
BackgroundLight-emitting diode fluorescence microscopy (LED-FM) has been shown to be more sensitive than conventional bright field microscopy using Ziehl-Neelsen (ZN) stain in detecting sputum smear positive tuberculosis in controlled laboratory cond
Externí odkaz:
https://doaj.org/article/11174a8488c5423e8e3de29d4b29747a
Autor:
Sharath Burugina Nagaraja, Ajay M V Kumar, Kuldeep Singh Sachdeva, Ranjani Ramachandran, Srinath Satyanarayana, Avi Bansal, Malik Parmar, Sarabjit Chadha, Sreenivas Nair, Ashok Kumar, Sven Gudmund Hinderaker, Mary Edginton, Puneet K Dewan
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e45554 (2012)
BACKGROUND: In India, the Revised National Tuberculosis Control Programme (RNTCP) has adopted the strategy of examining two specimens during follow-up culture examinations to monitor the treatment response of multi-drug resistant tuberculosis (MDR-TB
Externí odkaz:
https://doaj.org/article/324670294fda4911aeb3d4c00b7a30ac
Autor:
Ugra Mohan Jha, Srinath Satyanarayana, Puneet K Dewan, Sarabjit Chadha, Fraser Wares, Suvanand Sahu, Devesh Gupta, L S Chauhan
Publikováno v:
PLoS ONE, Vol 5, Iss 1, p e8873 (2010)
SETTING: Under India's Revised National Tuberculosis Control Programme (RNTCP), >15% of previously-treated patients in the reported 2006 patient cohort defaulted from anti-tuberculosis treatment. OBJECTIVE: To assess the timing, characteristics, and
Externí odkaz:
https://doaj.org/article/3ef2d10130b34547a94fbdb83e62c16d
Autor:
Aakshi Kalra, Akhil ThekkePurakkal, Raghuram Rao, Debadutta Parija, Vaibhav Ghule, Ajaz Lone, Tajamul Showket, Rajendra Joshi, Sanjay Sarin, Sarabjit Chadha
Publikováno v:
Bulletin of the World Health Organization. 101:179-190
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1afb3541fa2401342c81ee1660dd5db
https://doi.org/10.2471/blt.22.288277
https://doi.org/10.2471/blt.22.288277
Publikováno v:
International Journal of Infectious Diseases, Vol 108, Iss, Pp 557-567 (2021)
Objectives Globally, drug-resistant tuberculosis (DR-TB) is the leading cause of death globally related to antimicrobial resistance, affecting 500,000 emergent cases annually. In 2018, the first United Nations High-Level Meeting (UNHLM) on tuberculos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51506afe374f0299a554c11f5ac0200e
http://www.sciencedirect.com/science/article/pii/S1201971221005117
http://www.sciencedirect.com/science/article/pii/S1201971221005117